Роль Toll-подобных рецепторов и их эндогенных лигандов в патогенезе ревматоидного артрита (обзор литературы)
https://doi.org/10.14412/1995-4484-2016-78-85
Аннотация
Об авторе
М. Ю. ВолковРоссия
Москва, 115522 Москва, Каширское шоссе, 34А
Список литературы
1. Rock F. A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci. 1998;95:588-93. doi: 10.1073/pnas.95.2.588
2. Лебедев КА, Понякина ИД. Иммунология образраспознающих рецепторов: Интегральная иммунология. 2-е изд. Москва: Книжный дом «ЛИБРОКОМ»; 2013. 256 с. [Lebedev KA, Ponyakina ID. Immunologiya obrazraspoznayushchikh retseptorov: Integral’naya immunologiya [Immunology of image recognition receptors: Integrated Immunology]. 2nd ed. Moscow: Knizhnyi dom «LIBROKOM»; 2013. 256 p.].
3. Chen JQ, Szodoray P, Zeher M. Toll-like receptor pathways in autoimmune diseases. Clin Rev Allergy Immunol. 2015 Feb 17. [Epub ahead of print].
4. Cao Z, Henzel WJ, Gao X. IRAK: a kinase associated with the interleukin-1 receptor. Science. 1996;271:1128-31. doi: 10.1126/science.271.5252.1128
5. Mansell A, Smith R, Doyle SL, et al. Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Nat Immunol. 2006;7:148-55. doi: 10.1038/ni1299
6. Goh FG, Midwood KS. Intrinsic danger: activation of Toll-like receptors inrheumatoid arthritis. Rheumatology (Oxford). 2012;51(1):7-23. doi: 10.1093/rheumatology/ker257
7. Rogier R, Koenders MI, Abdollahi-Roodsaz S. Toll-like receptor mediated modulation of T cell response by commensal intestinal microbiota as a trigger for autoimmune arthritis. J Immunol Res. 2015;2015:527696. doi: 10.1155/2015/527696
8. Coenen MJH, Enevold C, Barrera P, et al. Genetic variants in toll-like receptors are not associated with rheumatoid arthritis susceptibility or anti-tumour necrosis factor treatment outcome. PLoS One. 2010;5:e14326. doi: 10.1371/journal.pone.0014326
9. Jaen O, Petit-Teixeira E, Kirsten H, et al. No evidence of major effects in several Toll-like receptor gene polymorphisms in rheumatoid arthritis. Arthritis Res Ther. 2009; 11:R5. doi: 10.1186/ar2589
10. Etem EO, Elyas H, Ozgocmen S, et al. The investigation of tolllike receptor 3, 9 and 10 gene polymorphisms in Turkish rheumatoid arthritis patients. Rheumatol Int. 2011;31:1369-74. doi: 10.1007/s00296-010-1472-8
11. Enevold C, Radstake TRD, Coenen MJH, et al. Multiplex screening of 22 single-nucleotide polymorphisms in 7 Toll-like receptors: an association study in rheumatoid arthritis. J Rheumatol. 2010;37:905-10. doi: 10.3899/jrheum.090775
12. Davis ML, LeVan TD, Yu F, et al. Associations of toll-like receptor (TLR)-4 single nucleotide polymorphisms and rheumatoid arthritis disease progression: an observational cohort study. Int Immunopharmacol. 2015;24(2):346-52. doi: 10.1016/j.intimp.2014.12.030
13. Sacre SM, Andreakos E, Kiriakidis S, et al. The Toll-like receptor adaptor proteins MyD88 and Mal/TIRAP contribute to the inflammatory and destructive processes in a human model of rheumatoid arthritis. Am J Pathol. 2007;170:518-25. doi: 10.2353/ajpath.2007.060657
14. Brentano F, Schorr O, Gay RE, et al. RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3. Arthritis Rheum. 2005;52:2656-65. doi: 10.1002/art.21273
15. Sacre SM, Lo A, Gregory B, et al. Inhibitors of TLR8 reduce TNF production from human rheumatoid synovial membrane cultures. J Immunol. 2008;181:8002-9. doi: 10.4049/jimmunol.181.11.8002
16. Ospelt C, Brentano F, Rengel Y, et al. Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: toll-like receptor expression in early and longstanding arthritis. Arthritis Rheum. 2008;58:3684-92. doi: 10.1002/art.24140
17. Roelofs MF, Wenink MH, Brentano F, et al. Type I interferons might form the link between Toll-like receptor (TLR) 3/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis (RA). Ann Rheum Dis. 2009;68:1486-93. doi: 10.1136/ard.2007.086421
18. Tamaki Y, Takakubo Y, Hirayama T, et al. Expression of Toll-like receptors and their signaling pathways in rheumatoid synovitis. J Rheumatol. 2011;38:810-20. doi: 10.3899/jrheum.100732
19. Radstake TRDJ, Roelofs MF, Jenniskens YM, et al. Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma. Arthritis Rheum. 2004;50:3856-65. doi: 10.1002/art.20678
20. Seibl R, Birchler T, Loeliger S, et al. Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium. Am J Pathol. 2003;162:1221-7. doi: 10.1016/S0002-9440(10)63918-1
21. Pierer M, Rethage J, Seibl R, et al Chemokine secretion of rheumatoid arthritis synovial fibroblasts stimulated by Toll-like receptor 2 ligands. J Immunol. 2004;172:1256-65. doi: 10.4049/jimmunol.172.2.1256
22. McGarry T, Veale DJ, Gao W, et al. Toll-like receptor 2 (TLR2) induces migration and invasive mechanisms in rheumatoid arthritis. Arthritis Res Ther. 2015 Jun 9;17:153. doi: 10.1186/s13075-015-0664-8.
23. Chen Z, Su L, Xu Q, et al. IL-1R/TLR2 through MyD88 divergently modulates osteoclastogenesis through regulation of nuclear factor of activated T cells c1 (NFATc1) and B lymphocyte-induced maturation protein-1 (Blimp1). J Biol Chem. 2015 Oct 19. pii: jbc.M115.663518. [Epub ahead of print]. doi: 10.1074/jbc.m115.663518
24. Hu F, Li Y, Zheng L, et al. Toll-like receptors expressed by synovial fibroblasts perpetuate Th1 and th17 cell responses in rheumatoid arthritis. PLoS One. 2014 Jun 17;9(6):e100266. doi: 10.1371/journal.pone.0100266
25. Roelofs MF, Joosten LA, Abdollahi-Roodsaz S, et al. The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells. Arthritis Rheum. 2005;52:2313-22. doi: 10.1002/art.21278
26. Caiello I, Minnone G, Holzinger D, et al. IL-6 amplifies _LR mediated cytokine and chemokine production: implications for thepathogenesis of rheumatic inflammatory diseases. PLoS One. 2014;9(10):e107886.
27. Kim K-W, Cho M-L, Oh H-J, et al. ТLR-3 enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis. Immunol Lett. 2009;124:9-17. doi: 10.1016/j.imlet.2009.02.006
28. Kinnebrew MA, Buffie CG, Diehl GE, et al. Interleukin 23 production by intestinal CD103(+)CD11b(+) dendritic cells in response to bacterial flagellin enhances mucosal innate immune defense. Immunity. 2012 Feb 24;36(2):276-87. doi: 10.1016/j.immuni.2011.12.011
29. Komai-Koma M, Li D, Wang E, et al. Anti-Toll-like receptor 2 and 4 antibodies suppress inflammatory response in mice. Immunology. 2014;143(3):354-62. doi: 10.1111/imm.12312
30. Meng L, Zhu W, Jiang C, et al. Toll-like receptor 3 upregulation in macrophages participates in the initiation and maintenance of pristane-induced arthritis in rats. Arthritis Res Ther. 2010;12(3):R103. doi: 10.1186/ar3034
31. Zhu W, Meng L, Jiang C, et al. Overexpression of toll-like receptor 3 in spleen is associated with experimental arthritis in rats. Scand J Immunol. 2012 Sep;76(3):263-70. doi: 10.1111/j.1365-3083.2012.02724.x
32. Yarilina A, DiCarlo E, Ivashkiv LB. Suppression of the effector phase of inflammatory arthritis by double-stranded RNA is mediated by type I IFNs. J Immunol. 2007;178(4):2204-11. doi: 10.4049/jimmunol.178.4.2204
33. Hayashi T, Gray CS, Chan M, et al. Prevention of autoimmune disease by induction of tolerance to Toll-like receptor 7. Proc Natl Acad Sci U S A. 2009;106(8):2764-69. doi: 10.1073/pnas.0813037106
34. Alzabin S, Kong P, Medghalchi M, et al. Investigation of the role of endosomal Toll-like receptors in murine collagen-induced arthritis reveals a potential role for ТLR7 in disease maintenance. Arthritis Res Ther. 2012;14(3):R142.
35. Chen SY, Shiau AL, Li YT, et al. Suppression of collagen-induced arthritis by intra-articular lentiviral vector-mediated delivery of Toll-like receptor 7 short hairpin RNA gene. Gene Ther. 2012;19(7):752-60. doi: 10.1038/gt.2011.173
36. Demaria O, Pagni PP, Traub S, et al. ТLR8 deficiency leads to autoimmunity in mice. J Clin Invest. 2010;120(10):3651-62.
37. Miles K, Heaney J, Sibinska Z, et al. A tolerogenic role for Tolllike receptor 9 is revealed by B-cell interaction with DNA complexes expressed on apoptotic cells. Proc Natl Acad Sci U S A. 2012;109(3):887-92. doi: 10.1073/pnas.1109173109
38. Begovich AB, Carlton VE, Honigberg LA, et al. A missense singlenucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet. 2004;75(2):330-7. doi: 10.1086/422827
39. Wang Y, Stanford S, Zhou W, et al. Rheumatoid arthritis-associated PTPN22 modulates toll-like receptor-mediated, type 1 interferon-dependent innate immunoregulation [abstract]. Arthritis Rheum. 2012;64(Suppl 10):2452.
40. Herman S, Fischer A, Pfatschbacher J, et al. A ТLR 9 antagonist diminishes arthritis severity in a rat model of rheumatoid arthritis. Ann Rheum Dis. 2011;70(Suppl 2):A39.
41. Isomä ki P, Alanä rä T, Isohanni P, et al. The expression of SOCS is altered in rheumatoid arthritis. Rheumatol Oxf Engl. 2007;46:1538-46. doi: 10.1093/rheumatology/kem198
42. Tsao J-T, Kuo C-C, Lin S-C. The analysis of CIS, SOCS1, SOSC2 and SOCS3 transcript levels in peripheral blood mononuclear cells of systemic lupus erythematosus and rheumatoid arthritis patients. Clin Exp Med. 2008;8:179-85. doi: 10.1007/s10238-008-0006-0
43. Sanjuan MA, Rao N, Lai KT, et al. CpG-induced tyrosine phosphorylation occurs via a TLR9-independent mechanism and is required for cytokine secretion. J Cell Biol. 2006;172(7):1057-68. doi: 10.1083/jcb.200508058
44. Kuznik A, Bencina M, Svajger U, et al. Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines. J Immunol. 2011;186(8):4794-804. doi: 10.4049/jimmunol.1000702
45. Thwaites R, Chamberlain G, Sacre S. Emerging role of endosomal Toll-like receptors in rheumatoid arthritis. Frontiers in Immunology. 2014;5:1. doi: 10.3389/fimmu.2014.00001
46. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002;418:191-5. doi: 10.1038/nature00858
47. Andersson U, Wang H, Palmblad K, et al. High mobility group 1 protein (Hmgb-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med. 2000;192:565-70. doi: 10.1084/jem.192.4.565
48. Schierbeck H, Lundback P, Palmblad K, et al. Monoclonal antiHMGB1 (high mobility group box chromosomal protein 1) antibody protection in two experimental arthritis models. Mol Med. 2011;17:1039-44. doi: 10.2119/molmed.2010.00264
49. Hamada T, Torikai M, Kuwazuru A, et al. Extracellular high mobility group box chromosomal protein 1 is a coupling factor for hypoxia and inflammation in arthritis. Arthritis Rheum. 2008;58:2675-85. doi: 10.1002/art.23729
50. Foell D, Kane D, Bresnihan B, et al. Expression of the proinflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis. Rheumatology. 2003;42:1383-9. doi: 10.1093/rheumatology/keg385
51. Madland TM, Larsen A, Brun JG. S100 proteins calprotectin and S100A12 are related to radiographic changes rather than disease activity in psoriatic arthritis with low disease activity. J Rheumatol. 2007;34:2089-92.
52. Shi Y, Evans JE, Rock KL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature. 2003;425:516-21. doi: 10.1038/nature01991
53. Liu-Bryan R, Scott P, Sydlaske A, et al. Innate immunity conferred by toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum. 2005;52:2936-46. doi: 10.1002/art.21238
54. Campo GM, Avenoso A, D'Ascola A, et al. The inhibition of hyaluronan degradation reduced pro-inflammatory cytokines in mouse synovial fibroblasts subjected to collagen-induced arthritis. J Cell Biochem. 2012;113:1852-67. doi: 10.1002/jcb.24054
55. Horton MR, Burdick MD, Strieter RM, et al. Regulation of hyaluronan-induced chemokine gene expression by IL-10 and IFN-γ in mouse macrophages. J Immunol. 1998;160:3023-30.
56. Midwood K, Sacre S, Piccinini AM, et al. Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat Med. 2009;15:774-80. doi: 10.1038/nm.1987
57. Goh FG, Piccinini AM, Krausgruber T, et al. Transcriptional regulation of the endogenous danger signal tenascin-C: a novel autocrine loop in inflammation. J Immunol. 2010;184:2655-62. doi: 10.4049/jimmunol.0903359
58. Zhao X, Okeke N, Sharpe O, et al. Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis. Arthritis Res Ther. 2008;10:R94. doi: 10.1186/ar2478
59. Sokolove J, Zhao X, Chandra PE, Robinson WH. Immune complexes containing citrullinated fibrinogen costimulate macrophages via Toll-like receptor 4 and Fcγ receptor. Arthritis Rheum. 2011;63:53-62. doi: 10.1002/art.30081
60. Sanchez-Pernaute O, Filkova M, Gabucio A, et al. Citrullination enhances the pro-inflammatory response to fibrin in rheumatoid arthritis synovial fibroblasts. Ann Rheum Dis. 2013;72:1400-6. doi: 10.1136/annrheumdis-2012-201906
61. Cordova KN, Willis VC, Haskins K, Holers VM. A citrullinated fibrinogen-specific T cell line enhances autoimmune arthritis in a mouse model of rheumatoid arthritis. J Immunol. 2013;190:1457-65. doi: 10.4049/jimmunol.1201517
62. Wendling U, Paul L, van der Zee R, et al. A conserved mycobacterial heat shock protein (hsp) 70 sequence prevents adjuvant arthritis upon nasal administration and induces IL-10-producing T cells that cross-react with the mammalian self-hsp70 homologue. J Immunol. 2000;164:2711-7. doi: 10.4049/jimmunol.164.5.2711
63. Wieten L, Berlo SE, ten Brink CB, et al. IL-10 is critically involved in mycobacterial HSP70 induced suppression of proteoglycan-induced arthritis. PLoS One. 2009;4:e4186. doi: 10.1371/journal.pone.0004186
64. O'Reilly S. Pound the alarm: danger signals in rheumatic diseases. Clin Sci (Lond). 2015;128(5):297-305. doi: 10.1042/CS20140467
65. Mullen L, Chamberlain G, Sacre S. Pattern recognition receptors as potential therapeutic targets in inflammatory rheumatic disease. Arthritis Res Ther. 2015;17:122. doi: 10.1186/s13075-015-0645-y
66. Idera Clinical Programs: Overview (2015) [цит. от 12.01.16]. Available from: http://www.iderapharma.com/
67. Musumeci D., Roviello GN, Montesarchio D. An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies. Pharm Ther. 2013;141(3):347-57. doi: 10.1016/j.pharmthera.2013.11.001
Рецензия
Для цитирования:
Волков М.Ю. Роль Toll-подобных рецепторов и их эндогенных лигандов в патогенезе ревматоидного артрита (обзор литературы). Научно-практическая ревматология. 2016;54(1):78-85. https://doi.org/10.14412/1995-4484-2016-78-85
For citation:
Volkov M.Yu. ROLE OF TOLL-LIKE RECEPTORS AND THEIR ENDOGENOUS LIGANDS IN THE PATHOGENESIS OF RHEUMATOID ARTHRITIS: A REVIEW OF LITERATURE. Rheumatology Science and Practice. 2016;54(1):78-85. (In Russ.) https://doi.org/10.14412/1995-4484-2016-78-85